• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颗粒大小对疫苗佐剂的影响。

The impact of size on particulate vaccine adjuvants.

作者信息

Shah Ruchi R, O'Hagan Derek T, Amiji Mansoor M, Brito Luis A

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.

出版信息

Nanomedicine (Lond). 2014 Dec;9(17):2671-81. doi: 10.2217/nnm.14.193.

DOI:10.2217/nnm.14.193
PMID:25529570
Abstract

Particulate adjuvants have been successful at inducing increased immune responses against many poorly immunogenic antigens. However, the mechanism of action of these adjuvants often remains unclear. As more potential vaccine targets are emerging, it is becoming necessary to broaden our knowledge on the factors involved in generating potent immune responses to recombinant antigens with adjuvants. While composition of adjuvants is integral in defining the overall performance of an adjuvant, some physical parameters such as particle size, surface charge and surface modification may also contribute to the potency. In this review, we will try to highlight the role of particle size in controlling the immune responses to adjuvanted vaccines, with a focus on insoluble aluminum salts, oil-in-water emulsions, polymeric particles and liposomes.

摘要

颗粒佐剂已成功诱导针对许多免疫原性较差的抗原产生增强的免疫反应。然而,这些佐剂的作用机制往往仍不清楚。随着越来越多潜在的疫苗靶点出现,有必要拓宽我们对使用佐剂产生针对重组抗原的有效免疫反应所涉及因素的认识。虽然佐剂的组成对于确定佐剂的整体性能至关重要,但一些物理参数,如粒径、表面电荷和表面修饰,也可能影响其效力。在本综述中,我们将试图强调粒径在控制对佐剂疫苗的免疫反应中的作用,重点关注不溶性铝盐、水包油乳液、聚合物颗粒和脂质体。

相似文献

1
The impact of size on particulate vaccine adjuvants.颗粒大小对疫苗佐剂的影响。
Nanomedicine (Lond). 2014 Dec;9(17):2671-81. doi: 10.2217/nnm.14.193.
2
Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine.颗粒大小和抗原结合对模型溶菌酶疫苗中铝盐佐剂有效性的影响。
J Pharm Sci. 2008 Dec;97(12):5252-62. doi: 10.1002/jps.21390.
3
Designing and building the next generation of improved vaccine adjuvants.设计和构建新一代改良疫苗佐剂。
J Control Release. 2014 Sep 28;190:563-79. doi: 10.1016/j.jconrel.2014.06.027. Epub 2014 Jul 3.
4
Chemical adjuvants for plasmid DNA vaccines.用于质粒DNA疫苗的化学佐剂。
Vaccine. 2007 May 10;25(19):3731-41. doi: 10.1016/j.vaccine.2007.01.120. Epub 2007 Feb 20.
5
Novel Adjuvants and Immunomodulators for Veterinary Vaccines.用于兽用疫苗的新型佐剂和免疫调节剂。
Methods Mol Biol. 2016;1349:63-82. doi: 10.1007/978-1-4939-3008-1_5.
6
Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.单独使用氢氧化铝佐剂的冻融应激足以降低含有天然抗原的重组乙型肝炎疫苗的免疫原性。
Vaccine. 2014 Jun 24;32(30):3765-71. doi: 10.1016/j.vaccine.2014.05.037. Epub 2014 May 20.
7
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine.新型 CCS 佐剂流感疫苗的免疫原性、保护效力和作用机制。
Vaccine. 2010 Sep 7;28(39):6527-41. doi: 10.1016/j.vaccine.2010.04.011. Epub 2010 Apr 21.
8
Toward precision adjuvants: optimizing science and safety.迈向精准佐剂:优化科学与安全。
Curr Opin Pediatr. 2020 Feb;32(1):125-138. doi: 10.1097/MOP.0000000000000868.
9
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.作为疫苗佐剂的聚(I:C)递药颗粒制剂。
Adv Drug Deliv Rev. 2013 Oct;65(10):1386-99. doi: 10.1016/j.addr.2013.05.013. Epub 2013 Jun 7.
10
Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.制剂和粒径对水包油乳液佐剂稳定性和免疫原性的影响。
Hum Vaccin Immunother. 2015;11(7):1853-64. doi: 10.1080/21645515.2015.1046660.

引用本文的文献

1
Immunological enhancement of micro-nanoparticle formulated with risedronate and zinc as vaccine adjuvant in aged mice.以利塞膦酸盐和锌作为疫苗佐剂配制的微纳米颗粒在老年小鼠中的免疫增强作用。
Immun Ageing. 2025 May 13;22(1):17. doi: 10.1186/s12979-025-00512-0.
2
Design of Novel Vaccines Based on Virus-Like Particles.基于病毒样颗粒的新型疫苗设计
Subcell Biochem. 2024;105:785-821. doi: 10.1007/978-3-031-65187-8_21.
3
Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases.壳聚糖在传染病防治策略中的应用
Pharmaceutics. 2024 Sep 13;16(9):1201. doi: 10.3390/pharmaceutics16091201.
4
Precision Nanovaccines for Potent Vaccination.用于高效接种的精准纳米疫苗。
JACS Au. 2024 Jul 31;4(8):2792-2810. doi: 10.1021/jacsau.4c00568. eCollection 2024 Aug 26.
5
Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity.作为治疗内脏利什曼病潜在疫苗的聚合物递送系统:制剂开发与免疫原性
Vaccines (Basel). 2023 Jul 31;11(8):1309. doi: 10.3390/vaccines11081309.
6
Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines.用于现代疫苗的基于纳米颗粒的佐剂和递送系统。
Vaccines (Basel). 2023 Jun 29;11(7):1172. doi: 10.3390/vaccines11071172.
7
Current status of nano-vaccinology in veterinary medicine science.兽医学纳米疫苗学的现状。
Vet Med Sci. 2023 Sep;9(5):2294-2308. doi: 10.1002/vms3.1221. Epub 2023 Jul 24.
8
The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants.粘膜粘附和粘膜渗透在基于聚合物的粘膜佐剂诱导的免疫反应中的作用。
Polymers (Basel). 2023 Mar 24;15(7):1615. doi: 10.3390/polym15071615.
9
Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity.含金刚烷和硬脂酰部分的NOD2激动剂的脂化对其体内佐剂活性有不同调节作用。
Pharmaceutics. 2022 Dec 9;14(12):2755. doi: 10.3390/pharmaceutics14122755.
10
Development and Efficacy Evaluation of a Novel Nano-Emulsion Adjuvant for a Foot-and-Mouth Disease Virus-like Particles Vaccine Based on Squalane.基于角鲨烷的口蹄疫病毒样颗粒疫苗新型纳米乳佐剂的研制与效果评价
Nanomaterials (Basel). 2022 Nov 8;12(22):3934. doi: 10.3390/nano12223934.